Getting your full genome sequenced for free is possible, but every no-cost option requires something in return: your time, your data, or both. The most accessible route for most healthy adults in the United States is enrolling in a federally funded research program. Other pathways exist for people with undiagnosed medical conditions or cancer, and a handful of commercial companies have experimented with free sequencing in exchange for sharing your health information with researchers.
The All of Us Research Program
The largest and most straightforward option is the NIH’s All of Us Research Program, a long-term study aiming to enroll at least one million people across the United States. Participants provide blood or saliva samples and receive clinical-grade whole genome sequencing at no cost. The program has already released over 245,000 genome sequences and identified more than 1 billion genetic variants, including 275 million that had never been reported before.
Enrollment is open to adults 18 and older who live in the U.S. You sign up through the program’s website or at a participating health center, complete consent forms, answer health surveys, and provide a biosample. In return, you get access to your own genomic results, including information about genetic ancestry and traits. The program was specifically designed to recruit a diverse population, so people from communities historically underrepresented in biomedical research are actively encouraged to join.
The trade-off is that your de-identified genomic and health data become available to approved researchers. Individual-level data is accessed through a controlled system, and researchers go through a registration process before they can work with it. Your name isn’t attached, but genomic data can never be fully anonymized (more on that below).
Programs for Undiagnosed or Rare Diseases
If you or a family member has a medical condition that doctors haven’t been able to diagnose despite extensive testing, the Undiagnosed Diseases Network (UDN) may be an option. This NIH-funded initiative exists specifically to help patients whose conditions have stumped specialists. Accepted participants are evaluated by physicians across multiple specialties and may have their DNA sequenced to look for genetic variants driving their symptoms.
Applications go through a centralized online portal called the UDN Gateway. You don’t need a doctor’s referral to apply, but the program is selective. It’s designed for people who have already been through significant medical workups without answers, not for general health curiosity. If accepted, the sequencing and clinical evaluation are provided at no charge.
Free Sequencing for Cancer Patients
Cancer patients can sometimes access genomic sequencing through clinical trials at no cost. The National Cancer Institute has run large precision medicine trials, like NCI-MATCH, where patients with advanced solid tumors, lymphoma, or myeloma received genomic profiling of their cancer cells to match them with targeted treatments. That particular trial is no longer enrolling, but similar trials continue to open. Searching ClinicalTrials.gov for “genomic sequencing” along with your cancer type is the most reliable way to find active studies.
Many major cancer centers also offer tumor sequencing as part of routine care, and insurance increasingly covers it for patients with advanced or hard-to-treat cancers. This isn’t whole genome sequencing of your healthy DNA, though. It’s targeted sequencing of your tumor to guide treatment decisions.
Open Science and Volunteer Projects
The Personal Genome Project takes a radically different approach. Participants agree to make their genomic data and personal health records publicly available to anyone, with no promise of privacy. Before enrolling, you must pass an exam demonstrating that you understand genomic science and the specific risks involved, including the possibility of being re-identified, discovering unexpected family relationships like nonpaternity, and potential impacts on insurance. The project provides genetic data including hundreds of thousands of markers and, for some participants, more comprehensive sequencing. It’s a genuine contribution to open science, but the privacy trade-off is absolute.
Other university-based studies have offered free genotyping in the past. The University of Michigan’s Genes for Good program, for example, provided free genetic data to participants who completed health surveys through Facebook. That program has reached capacity and is no longer collecting data, though past participants can still download their raw results. Programs like these come and go as funding cycles change, so checking major research university websites periodically can turn up new opportunities.
Commercial Options With Strings Attached
A few direct-to-consumer companies have offered free or heavily subsidized genome sequencing in exchange for your health data. Nebula Genomics launched with a model where customers could earn credits toward free sequencing by answering detailed health questionnaires covering topics like cancer history, cardiovascular disease, medications, physical activity, and smoking. Those who preferred not to share personal health information could pay a reduced fee instead.
These commercial models shift over time. Companies may change pricing, alter what data they collect, or shut down entirely. Before signing up, read the data-sharing terms carefully. You’re essentially trading your health information for sequencing, and that information may be sold or licensed to pharmaceutical companies or other third parties. Unlike federally funded research programs, commercial companies operate under fewer restrictions on how they use participant data.
What “Free” Actually Costs: Privacy Risks
Every free sequencing program involves sharing your genetic information with someone. The privacy implications are worth understanding before you enroll. Your DNA sequence is unique to you (unless you have an identical twin), which means genomic data can never be truly de-identified in the way other medical records can. A 2013 study demonstrated that research participants could be re-identified by cross-referencing genomic databases with genealogical records and public information.
The risk is higher for people in small or identifiable communities. If you belong to a specific ethnic group, live in a geographically defined community, or have an ultra-rare disease, the pool of people who share your characteristics is small enough that de-identification offers less protection. Close family relationships within these groups make it even harder to keep individual identities private.
Federal research programs like All of Us use controlled access systems and data use agreements to limit who sees your information. The Personal Genome Project offers no privacy protections at all, by design. Commercial companies fall somewhere in between, governed by their own terms of service rather than federal research regulations.
If You’d Rather Just Pay
For context, whole genome sequencing has dropped dramatically in price. Academic medical centers now charge around $1,100 to $1,400 per sample for translational whole genome sequencing, and consumer-facing companies offer it for a few hundred dollars depending on the depth of analysis. If your main goal is getting your raw genomic data without sharing it with researchers or the public, paying out of pocket is faster and simpler than any free option. Most consumer services deliver results within a few weeks, while research programs may take months.
The free routes make the most sense if you’re genuinely interested in contributing to research, if you have an undiagnosed condition that might benefit from expert analysis, or if the cost of commercial sequencing is a barrier. Each pathway gives you something different: All of Us provides clinical-grade results with moderate privacy protections, the UDN offers diagnostic expertise for complex cases, and open science projects give you data in exchange for full transparency.